博尔特佐米布诱导的外围神经病变:从分子机制到临床管理
Yuting Yan1, Yanqi Song2, Quan Zhang3
1Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Frontiers in pharmacology
|December 12, 2025
概括
博尔特佐米布诱导的周围神经病变 (BIPN) 是多发性骨髓瘤治疗的常见副作用. 这篇评论探讨了BIPN的BIPN.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 博尔特佐米布 (BTZ) 是一种蛋白酶体抑制剂,有效对抗多发性骨髓瘤 (MM).
- 博尔特佐米布诱导的周围神经病变 (BIPN) 是BTZ治疗的常见和衰弱的副作用.
- BIPN显著影响MM治疗方案,往往需要调整剂量.
研究的目的:
- 提供关于BIPN.当前研究的全面审查.
- 阐明BIPN.的临床表现,病理生理学和新兴治疗方法.
- 确定潜在的治疗点,并改善BIPN.的临床管理.
主要方法:
- 对BIPN.的临床前和临床研究的文献综述.
- 对涉及BIPN的分子机制和病理生理路径的分析.
- 对BIPN管理的当前和新型治疗策略的评估.
主要成果:
- BIPN呈现出各种神经系统症状,影响患者的生活质量.
- 多种分子机制,包括氧化应激和线粒体功能障碍,有助于BIPN.
- 目前,BIPN的有效治疗方法有限,这凸显了大量未满足的需求.
结论:
- 了解BIPN的分子基础对于开发向疗法至关重要.
- 需要标准化和有效的治疗策略,以改善BTZ上MM患者的治疗结果.
- 对新型治疗方法的进一步研究对于管理这种具有挑战性的副作用至关重要.
相关概念视频
Peripheral Artery Disease IV: Nursing Management
316
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
316
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
318
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
318
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
518
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
518
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
787
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
787
Pharmacodynamics: Overview and Principles
2.7K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.7K
Therapeutic Drug Monitoring: Overview and Classification
270
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
270


